KERA BROWNE: Open Payments
NPI 1467099580 · FORT MYERS, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$632 in 20 payments from 9 companies in 2025. Trend: 2023 $424 · 2024 $471 · 2025 $632
Food & beverage: $632
| Company | Payments | Amount |
|---|---|---|
| Kerecis Limited | 2 | $185 |
| ABBVIE INC. | 6 | $171 |
| Janssen Biotech, Inc. | 5 | $113 |
| E.R. Squibb & Sons, L.L.C. | 1 | $35 |
| Incyte Corporation | 2 | $31 |
| Lilly USA, LLC | 1 | $30 |
| Regeneron Healthcare Solutions, Inc. | 1 | $25 |
| Verrica Pharmaceuticals Inc. | 1 | $22 |
| ConvaTec Inc. | 1 | $20 |
Products named: Kerecis SurgiClose, SKYRIZI, TREMFYA, Sotyktu, OPZELURA, EBGLYSS, DUPIXENT, YCANTH.
Industry payments across FL — which companies pay providers there.
